While many sleep compounds target GABA receptors (promoting sedation), DSIP is studied for its potential to promote natural sleep architecturespecifically increasing slow-wave sleep without necessarily causing sedation
Zummo SM & Karol MH (1996) Indoor air pollution: Acute adverse health effects and host susceptibility
Patients Can Maintain Their Weight Loss After GLP-1s With Ongoing Support Some of the most common questions asked about GLP-1s are, is weight regain post-GLP-1s inevitable? How can we help people keep the weight off after GLP-1 discontinuation? And what does the real-world evidence show? In my conversations with benefits leaders across the country, these questions are at the forefront of their minds
If you are on HRT, have prior GLP-1 failures, or carry a complex history, Mochis live specialist model is the right starting point
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
